Greater Than One (GTO) has been recognized by PM360 for its success in conceiving and launching a virtual campaign to support OXLUMO® (lumasiran), a first-in-class therapy developed by Alnylam.
Soliton and GTO joined forces in September 2020 to help launch the revolutionary RESONIC Rapid Acoustic Pulse™ (RAP) device and establish Soliton as a leader in the aesthetics industry. Today, we are beyond proud to announce the work we have done for RESONIC.
VITAS Healthcare has selected GTO to support their strategic shifts and enhanced ROI from marketing initiatives.
Soliton and GTO join forces to help launch their revolutionary Rapid Acoustic Pulse Device in 2021 and establish them as leaders in the aesthetic industry.